New FDA Approved Treatment For Bacterial Vaginosis (BV) [transcript] [audio]

Guest: Beth Battaglino, RN  

Presenter: Neal Howard

Guests Bio: Beth Battaglino, RN, brings a unique combination of sharp business expertise and, as a practicing registered nurse, medical knowledge to her role as CEO of HealthyWomen, a non-profit organization providing women with in-depth, objective, medically-approved information on a broad range of women’s health issues. Her management and marketing expertise is particularly critical as Healthy Women moves to expand its outreach to millions of women across the country through updated technology, wider program distribution and new public education and awareness efforts. Beth is responsible for setting the strategic direction of HealthyWomen and building alliances with corporations, health care professionals and consumer groups. She also serves as the organization’s chief spokesperson, regularly speaking at corporate, non-profit, community and media events. In addition to her nursing degree, Beth holds degrees in political science, business and public administration from Marymount University and the University of Oklahoma.

Segment overview: Beth Battaglino, RN, CEO of HealthyWomen.org, discusses what the recent FDA approval of Solosec™ (secnidazole) will mean for the women’s health community.